Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sujal M. Patel currently holds 10,366,721 shares of Nautilus Biotechnology, Inc. (NAUT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sujal M. Patel has been a net seller of NAUT stock. They have purchased $2.0M and sold $8.1M worth of shares.
Sujal M. Patel's most recent insider trade was on Mar 4, 2026, when they purchased 25,000 shares at $2.61 per share.
Sujal M. Patel serves as Executive at Nautilus Biotechnology, Inc. (NAUT). They have executed 104 insider transactions totaling $10.2M over their tenure at the company.
Sujal M. Patel holds the position of Executive at Nautilus Biotechnology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Sujal M. Patel has shown a selling trading pattern, with $2.0M in total purchases and $8.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Sujal M. Patel was on Dec 17, 2010, when they sold $69.7M worth of ISLN shares. This transaction involved 2,060,164 shares at $33.85 per share.
Sujal M. Patel currently owns 10,366,721 shares of Nautilus Biotechnology, Inc. (NAUT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sujal M. Patel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sujal M. Patel has 104 Form 4 filings on record as an insider at Nautilus Biotechnology, Inc..
Set alerts for Sujal M. Patel and 40,000+ other insiders.